REVLIMID should not be used to treat people who have chronic lymphocytic leukemia (CLL) unless they are participants in a controlled clinical trial. It is not known if REVLIMID is safe and …

Aug 12, 2025 · Revlimid is used to treat types of multiple myeloma, mantle cell lymphoma, follicular lymphoma and marginal zone lymphoma and anemia in myelodysplastic syndromes. …

Lenalidomide, sold under the brand name Revlimid among others, is a medication used to treat multiple myeloma, smoldering myeloma, various indolent lymphomas, and myelodysplastic …

Dec 30, 2024 · Find patient medical information for Lenalidomide (Revlimid) on WebMD including its uses, side effects and safety, interactions, pictures, warnings, and user ratings

Aug 1, 2025 · Description Lenalidomide is used to treat anemia (low red blood cells) in patients with a certain type of myelodysplastic syndrome (MDS). Patients with MDS may have very low …

REVLIMID has demonstrated a significantly increased risk of deep vein thrombosis (DVT) and pulmonary embolism (PE), as well as risk of myocardial infarction and stroke in patients with …

Mar 10, 2025 · Learn about the uses, side effects, dosage, and more of Revlimid. It’s a prescription oral capsule used to treat certain blood cancers.

Since REVLIMID is primarily excreted unchanged by the kidney, adjustments to the starting dose of REVLIMID are recommended to provide appropriate drug exposure in patients with …

REVLIMID is not indicated and is not recommended for the treatment of patients with chronic lymphocytic leukemia (CLL) outside of controlled clinical trials. REVLIMID is only available …

Feb 8, 2024 · Revlimid (lenalidomide) is an oral medication taken once a day to treat blood cancers such as multiple myeloma, myelodysplastic syndromes, and certain types of non …